Jim Hlavac
Alex Avella Archila
Assistant Lecturer, Translation and Interpreting Studies, Faculty of Arts
For CALD communities, this may mean being able to access interpreting services, or receiving translated information about the pandemic.
Adequate translations must carefully consider the needs of the target audience:
Are they literate?
Who do they usually get their information from?
CALD communities often prefer to access information through their own networks, as their trust of government authorities may be low.
Lost in translation
Many translations of COVID-19 information were deemed unacceptable, as they didn’t recognise the diversity within ethnic communities, and failed to prioritise communication tailored for specific target audiences.
iTWire Tuesday, 11 May 2021 11:20 Black Dog Institute and SAS optimising mental health hub for frontline workers
Shares
The Black Dog Institute s mental health platform tailored to frontline healthcare workers - TEN - was built with the analytical power of SAS and has reached 33,000 Australian healthcare professionals. However, its continued funding now rests on the result of the 2021-22 federal budget.
COVID-19 has hit everyone hard, and frontline healthcare workers are no exception, with relentless demands and pressures affecting their mental wellbeing in their professional and personal life. As part of its $74 million package to support the mental and health and wellbeing of all Australians, the Commonwealth Department of Health funded the Black Dog Institute to develop an online support platform tailored to these workers. This was released as The Essential Network, or TEN.
Australian Woman Dies from Blood Clots Days after Getting AstraZeneca Vaccine
May 10th 2021, 5:55 pm
Third reported case of thrombosis, or blood clots in the arteries and veins, linked to the AstraZeneca vaccine in Australia.
Image Credit:
Share
Email
This was announced by the
Therapeutic Goods Administration (TGA) on Friday, April 16, after it met to investigate the link between the vaccine and the patient’s death. According to the TGA, the person who died was Genene Norris, a 48-year-old woman from the Central Coast region of the state of New South Wales.
Norris received her dose of the AstraZeneca coronavirus vaccine on April 9. She was rushed to the hospital the following day after developing blood clots. She was then placed on dialysis and in an intensive care unit. She never recovered, and she died on April 14.
This was announced by the
Therapeutic Goods Administration (TGA) on Friday, April 16, after it met to investigate the link between the vaccine and the patient’s death. According to the TGA, the person who died was Genene Norris, a 48-year-old woman from the Central Coast region of the state of New South Wales.
Norris received her dose of the AstraZeneca coronavirus vaccine on April 9. She was rushed to the hospital the following day after developing blood clots. She was then placed on dialysis and in an intensive care unit. She never recovered, and she died on April 14.
This is the third reported case of thrombosis, or blood clots in the arteries and veins, linked to the AstraZeneca vaccine in Australia. Norris and the other two patients also presented to the hospital with thrombocytopenia or low platelet counts.
Nimble Failure: The Australian COVID-19 Vaccination Program
Nimble Failure: The Australian COVID-19 Vaccination Program
“I am not going to be talking about numbers today,” Australia’s Chief Medical Officer Paul Kelly told Australia’s Radio National on April 12. This echoed suggestions from the Australian Prime Minister, Scott Morrison, who had adopted the position that Australia best forget meeting any clear vaccination targets. Having left battling the pandemic to State governments, the Federal government has found itself unable to execute its program, if one dare call it that.
Part of the monumental failings of the government can be put down to its stubbornness in prioritising the use of one vaccine. AstraZeneca was meant to be the vaccine wonder, the Godhead, the miraculous deliverer. CSL, Australia’s only vaccine manufacturer, was given the task of producing the majority of 54 million ordered doses at its Broadmeadows factory in Melbourne. Many of those now